Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic hypercalciuria.

Scott E Liebman1, Jeremy G Taylor, David A Bushinsky

  • 1University of Rochester School of Medicine and Dentistry, Nephrology Division, Strong Memorial Hospital, 601 Elmwood Avenue, Box 675, Rochester, NY 14642, USA. scott_liebman@urmc.rochester.edu

Current Rheumatology Reports
|March 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives.

Journal of the American Society of Nephrology : JASN·2025
Same author

Early Steps of the Kidney Transplant Process: What Are the Experiences of Dialysis Social Workers?

Clinical transplantation·2025
Same author

The Effects of a Whole-Food Plant-Based Nutrition Education Program on Blood Pressure and Potassium in Chronic Kidney Disease: A Proof-of-Concept Study.

Nutrients·2025
Same author

Exploring Patient Needs and Preferences in CKD Education: A Cross-Sectional Survey Study.

Kidney360·2024
Same author

VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.

Journal of the American Society of Nephrology : JASN·2024
Same author

Magnesium Decreases Urine Supersaturation but Not Calcium Oxalate Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.

Nephron·2024
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
Same journal

Management of IgG4-Related Disease.

Current rheumatology reports·2026
See all related articles

Idiopathic hypercalciuria (IH) causes excess calcium in urine, increasing kidney stone risk. Treatment involves diet changes and medications like thiazide diuretics to prevent stone formation.

Area of Science:

  • Nephrology
  • Metabolic Disorders
  • Urology

Background:

  • Hypercalciuria is a common metabolic disorder linked to nephrolithiasis.
  • Rising kidney stone prevalence necessitates understanding hypercalciuria's causes and treatments.
  • Idiopathic hypercalciuria (IH) is the most frequent cause, characterized by excess urinary calcium without a clear etiology.

Purpose of the Study:

  • To focus on the pathogenesis and treatment of idiopathic hypercalciuria.
  • To highlight the systemic nature of IH involving calcium transport dysregulation.
  • To outline therapeutic strategies for preventing calcium oxalate stone formation.

Main Methods:

  • Review of calcium homeostasis and transport mechanisms in intestine, bone, and kidney.
  • Discussion of dietary interventions: increased fluid intake, salt and animal protein restriction, normal calcium intake.

Related Experiment Videos

  • Evaluation of pharmaceutical interventions, specifically thiazide diuretics, for reducing urinary calcium.

    • Main Results:

    • Idiopathic hypercalciuria results from dysregulated calcium transport across multiple sites.
    • Dietary modifications can significantly impact urinary calcium levels and stone risk.
    • Thiazide diuretics effectively reduce urinary calcium excretion, aiding in stone prevention.

    Conclusions:

    • Idiopathic hypercalciuria is a complex systemic disorder requiring multifaceted treatment approaches.
    • Effective management focuses on preventing stone formation by reducing calcium oxalate supersaturation.
    • A combination of dietary and pharmaceutical strategies is crucial for managing IH and nephrolithiasis.